Ospraie Ag Science LLC - Jul 12, 2022 Form 4 Insider Report for MARRONE BIO INNOVATIONS INC (MBII)

Role: Director, Other*, 10%+ Owner
Signature: OSPRAIE AG SCIENCE LLC By: OAS MM, LLC, its managing member Name: /s/ Dwight Anderson Title: Managing Member
Stock symbol: MBII
Transactions as of: Jul 12, 2022
Transactions value $: $0
Form type: 4
Date filed: 7/15/2022, 09:09 AM
Previous filing: Dec 17, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MBII	Common Stock, $0.00001 par value	Disposition pursuant to a tender of shares in a change of control transaction		-70.8M	-100%		0	Jul 12, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ospraie Ag Science LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Disposed of pursuant to the Agreement and Plan of Merger dated March 16, 2022 by and among the Issuer, Bioceres Crop Solutions Corp. and BCS Merger Sub, Inc. (the "Merger Agreement") in exchange for 6,233,590 ordinary shares of Bioceres Crop Solutions Corp. having a market value of $9.44 per share at closing on the effective date of the merger.
F2	Ospraie Management, LLC ("Ospraie Management") is the investment manager of Ospraie Ag Science LLC ("Ospraie LLC") and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer held by Ospraie LLC. Ospraie Holding I, LP ("Ospraie Holding") may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. ("Ospraie Inc.") may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding. OAS MM, LLC may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie LLC. Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and sole managing member of OAS MM, LLC. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any.

Content

Disposed of pursuant to the Agreement and Plan of Merger dated March 16, 2022 by and among the Issuer, Bioceres Crop Solutions Corp. and BCS Merger Sub, Inc. (the "Merger Agreement") in exchange for 6,233,590 ordinary shares of Bioceres Crop Solutions Corp. having a market value of $9.44 per share at closing on the effective date of the merger.

Ospraie Management, LLC ("Ospraie Management") is the investment manager of Ospraie Ag Science LLC ("Ospraie LLC") and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer held by Ospraie LLC. Ospraie Holding I, LP ("Ospraie Holding") may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. ("Ospraie Inc.") may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding. OAS MM, LLC may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie LLC. Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and sole managing member of OAS MM, LLC. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any.

Remarks:

Each of Ospraie Ag Science LLC, Ospraie Management, LLC, Ospraie Holding I, LP, Ospraie Management, Inc., OAS MM, LLC and Dwight Anderson (collectively, the "Reporting Persons") may be deemed a director by deputization of Marrone Bio Innovations, Inc. (the "Issuer") by virtue of the fact that Messrs. Robert A. Woods, Yogesh Mago, Keith McGovern and Stuart Woolf, representatives of the Reporting Persons, served on the board of directors of the Issuer prior to the closing of the merger contemplated by the Merger Agreement.